of Gly-PI degradation correlated with the liberation of myr-DAG, which became detectable after 1 min of IL-2 treatment and reached a maximum after 2 min ( Fig. 2A) .
These analyses indicate that the hydrolysis of Gly-PI represents an early event in the transduction ofthe IL-2 signal in B lymphocytes. B cells synthesize a Gly-PI that is sensitive to hydrolysis by PI-PLC and is rapidly degraded in response to IL-2. The products of the hydrolysis, myr-DAG and PI-glycan, are generated within minutes after IL-2 treatment, well before any proliferation or differentiation can be detected. The concentrations of IL-2 that induce these responses indicate that transduction is mediated through high-affinity receptors (1) , and because the p75 component of the receptor is the signal transmitter (13) , the observed biochemical response is associated with that protein. Finally, the myr-DAG and IP-glycan responses show the same patterns of IL-2 stimulation and IL-4 inhibition as the proliferative and j chain gene responses.
Although these data were obtained with a B cell model, there is suggestive evidence from studies of IL-2-IL-4 antagonisms that Gly-PI hydrolysis may be involved in IL-2 signal transduction in other lymphoid cells. For example, IL-4 has been shown to inhibit IL-2-induced proliferation of anti-CD3-stimulated T lymphocytes (14) and to block both the proliferative and cytotoxic activities of IL-2-stimulated lymphokine-activated killer (LAK) cells (15) . Definitive evidence for the transducing function of the Gly-PI system will require the demonstration that the hydrolysis products function as second messengers in IL-2 signaling. The next step is to determine whether myr-DAG or IPglycan activates enzymes identified with IL-2 responses, such as omithine decarboxylase (16) , or enzymes associated with other hormone responses, such as insulin-activated cAMP phosphodiesterase (8) .
This study also indicates that the IL-2 and IL-4 signals are transduced by different pathways that intersect at an early point during the relay of their respective signals. By itself, IL-4 does not stimulate Gly-PI hydrolysis; yet it acts rapidly and efficiently to block the IL-2-induced hydrolysis. This antagonism is unlikely to be mediated by down-regulation of the IL-2 receptors. Studies in several systems have shown that IL-4 decreases the expression of IL-2 receptors (17, 18) , but the suppression occurs relatively slowly and is only partially effective. The observed 35 to 65% decrease in receptor number over 1 to 4 hours (18) cannot account for the rapid inhibition of Gly-PI turnover by IL4. It is more likely, therefore, that IL-4 exerts its antagonistic action by competing for, or preventing the function of, some component required for the activation of a Gly-PI-specific phospholipase C. One candidate for such a component has been suggested by recent reports (19) that a tyrosine kinase is associated with the IL-2 receptor. With these clues, it should be possible to delineate the exact pathway by which the generation of myr-DAG and IP-glycan is stimulated by IL-2 and inhibited by IL-4. This pathway may participate in the immune response, because the relative concentrations of the two lymphokines in lymphoid tissues may determine whether the antigen-activated B cell is driven by IL-2 to pentamer IgM synthesis or driven by IL-4 to switch to the synthesis of monomer IgG, and IgE (20 FDA to fluorescein (7) or CBAM to calcein blue (high calcein blue flourescence); they represented about 50% of the preparation and were well resolved from other populations, which probably include dead cells, nuclei, yolk, and debris. The live cell population had a broad distribution of forward light scatter values because of heterogeneity in cell size and the presence of some incompletely dissociated cells (Fig. 1, right) . Unlike in many heterogeneous cell populations (4), however, in the live cell population there were no subpopulations with distinctive forward and large-angle light scatter profiles, possibly because there has been little cellular differentiation at this early stage in development. In the following ex- periments, we used PI staining and forward light scatter measurements to exclude from analysis dead cells, large cell aggregates, and most debris; in some experiments, we also used CBAM staining to exclude cell-sized debris and a rare population of autofluorescent particles.
Cultured mammalian cells that express 3-galactosidase can be fluorescently stained with the P-galactosidase substrate fluorescein di-P-D-galactopyranoside (FDG) and remain viable (8) . Nonfluorescent FDG is briefly introduced into cells at 37C under hypotonic conditions, and the fluorescent reaction product fluorescein accumulates in cells expressing P-galactosidase. The P-galactosidase reaction is carried out under iso- tonic conditions, and at 4TC so that fluorescein will not leak from the cells (8 4 JANUARY 1991 to show that WACS can be used to purify cells solely on the basis of their pattern of gene expression. Early in embryogenesis there are no morphological differences between en-expressing cells and nonexpressing cells, although the expressing cells become the posterior part of each segment (12) . Cells from 4-to 6-hour-old en-lacZ embryos were treated with FDG, the fluorescent cells were sorted, and P-galactosidase and en expression in the cells were determined by antibody staining (Fig. 3) . Essentially all sorted cells expressed both proteins, whereas only rare cells in a nonfluorescent control population expressed either; we obtained a similar result using protein immunoblots of cell extracts probed with anti-,B-galactosidase antibodies (13) . Thus, the FACS assay accurately measures expression of the endogenous gene, and WACS can separate stripes of en-expressing cells, the incipient posterior compartment cells, from nonexpressing cells of the interstripes.
For the study ofdevelopment in vitro, the purified cells must be capable of executing their normal developmental program in culture. To test for developmental competency, we purified neuronal precursor cells from a strain with lacZ expression in neuroblasts and cells derived from neuroblasts (14) (Fig.  4) . After growth in culture for 1 day, 33 to 41% of the purified cells had long slender processes characteristic of neurons (Fig. 4) (15), and the cell bodies and processes ofthe differentiated cells stained with anti-horseradish peroxidase (HRP) antisera (7), which recognizes a neuronal surface antigen (16) . Only a few percent (1.6 to 5%) of unpurified control cells had this morphology under the same culture conditions. Purified cells that did not acquire neuronal morphology may have arrested at an earlier developmental stage, possibly because culture conditions are suboptimal or because differentiation of these cells requires interactions with other cell types.
In the purified culture, neurons with one or two processes were most common, but there were also rare cells with more than two neurites. Many cells were present in clusters of two or more cells of similar morphology (Fig. 4) after fertilization and continues for several hours throughout embryogenesis (18) .
Other purification methods, such as elutriation (19) and differential cell adhesion (19, 20) , have been successfully applied to D. melanogaster embryo cells to enrich for certain cell types, but they lack the purification power of WACS, and they are based on intrinsic physical differences among cells and so are not inherently generalizable. In contrast, WACS is applicable to virtually any cell type at any stage of development, so long as the cells can be selectively marked with 3-galactosidase and viably separated from neighboring cells. Given the large number of existing lacZ strains and the ease of generating new ones (5), it may be possible to mark and purify most types of D. melanogaster cells (21) . If necessary, FDG staining of 3-galactosidase-expressing cells can be used in combination with other cell markers, including other fluorescent markers that can be distinguished from fluorescein by means of multiparameter FACS.
The stage is now set to begin purification of the different cells of an animal from a particular developmental stage for molecular analysis and for reconstructing developmental interactions from purified cells in vitro. For instance, it should be possible to purify wingless-expressing cells, which neighbor the en-expressing cells in each segment, to test in vitro the proposal that wingless-expressing cells are required for maintenance of en expression during embryogenesis (22) . WACS may be of special importance in the study of the nervous system, where many cell types interact to form a functional network. WACS should also be applicable to other animals for which germ-line transformation with lacZ transgenes is possible, such as the mouse and the nematode worm (23) .
Because maximal sorting speeds of current FACS instruments approach -1O7 cells (or -103 embryos) per hour, 105 to 107 purified cells can be obtained in several hours by WACS if the cells of interest represent a reasonable proportion of total cells. This is enough for most cell-based analyses, and it should be enough for constructing cell type-specific cDNA libraries and for detecting proteins and DNA binding activities using sensitive techniques (24) . Cell yields can be increased if other purification techniques are used to enrich for the cells of interest before WACS, or it may be possible to establish continuous cell lines from the purified cells. Eggs (_103) were aged at 25WC, washed with 0.7% NaCl, and dechorionated for 2 min in 2.5% sodium hypochlorite. Subsequent steps were at 4CC. Embryos were washed with Schneider's medium (SM) (Gibco #350-1720AJ), resuspended in approximately five times their settled volume of SM, and disrupted by dounce homogenization (seven strokes, type A pestle). The cell suspension was centrifuged (5 min, 40qg), and the cell pellet was resuspended in SM. This washing procedure was repeated three times, and the cell suspension was filtered through Nitex (-50 by 50 glm pore size) to remove large debris and cell aggregates. PI was added to 10 ig/ml and CBAM (Molecular Probes) to 10 liM. The cells were incubated at 4CC for 10 min or more to allow hydrolysis of CBAM. Just before FACS, we pelleted cells and resuspended them in fresh SM containing PI (10 jug/ml) to reduce background fluorescence from free CBAM. CBAM treatment at 1 to 10~iM had no significant effects on S2 cell doubling time or on the efficiency of differentiation of unpurified embryo cells into neurons and myocytes. 27. Dual laser FACS, data collection, and multiparameter analysis were with a modified Becton Dickinson FACStar Plus and data analysis regimes of FACS/ DESK (28 (1, 2) . The behavioral and neural plasticity seen after repeated exposure to opiates is experience-dependent and in many respects is similar to learning-in fact, learning has been suggested to be important in the development of tolerance and dependence (3, 4) . Despite many years of study, the mechanisms underlying opiate tolerance and dependence are still relatively poorly understood.
Excitatory amino acid systems have a role in behavioral and neural plasticity. In particular, the N-methyl-D-aspartate (NMDA) receptor is involved in neuronal development, long-term potentiation, kindling, learning, and memory (5) . In the present studies we examined the potential role of NMDA receptors in the development of tolerance and dependence by determining the effects of an NMDA receptor antagonist on the behavioral changes that occur with repeated administration of morphine to rats (6) .
Animals receiving 10 mg of morphine per kilogram of body weight (10 mg/kg of morphine) displayed maximal analgesia on days 1 and 3 oftreatment whether they were treated with saline or MK-801. In salinetreated animals the analgesic response to morphine displayed rapid development of tolerance, reaching baseline latencies by days 7 to 9 (Fig. 1A) . In contrast, animals treated with 0.1 mg/kg of MK-801 showed considerably less tolerance, maintaining an analgesic response throughout morphine treatment. This effect was dose-dependent; animals treated with 0.03 mg/kg ofMK-801 showed tolerance to the analgesic effect of morphine that was similar to that in salinepretreated animals, while animals treated with 0.1 or 0.3 mg/kg of MK-801 were analgesic throughout the testing period ( Fig. 2A) . The increased analgesia seen in the MK-801-treated group was not due to analgesic actions of MK-801 alone or to an acute analgesic interaction between MK-801 and morphine. First, animals treated acutely with MK-801 (0.03, 0.1, 0.3, or 3.0 mg/kg) showed no change in tail-flick latency, demonstrating the lack of effect of this drug alone on pain responsiveness (Fig. 3) . Additionally, animals treated acutely with MK-801 (0.03, 0.1, or 0.3 mg/kg) and then with a mildly analgesic dose of morphine (1.0 mg/kg) had tail-flick latencies no greater than saline-pretreated animals, demonstrating the lack of acute interaction between these drugs (Fig. 3) . Despite the absence of analgesia observed with MK-801 alone or in combination with an acute injection of morphine, we considered the possibility that this drug may have unmasked "hidden" analgesia in the morphine-tolerant animal and may therefore have affected the expression rather than the development of morphine tolerance. However, the data from day 10 of treatment indicate that this was not the case; animals that had been treated with saline and morphine on days 1 through 9, then challenged with MK-801 and morphine on day 10 showed no greater analgesia than that seen the previous day, demonstrating that MK-801 does not affect the analgesia in an already morphine-tolerant animal (Fig. 1 B) . Moreover, animals that had been treated with MK-801 and morphine on days 1 through 9, then given morphine alone on day 10, displayed considerable analgesia on day 10 despite the lack of MK-801 pretreatment on this day (Figs. 1B and 2B ), suggesting that MK-801 need not be present during testing to observe analgesia in the chronically treated
